DIALYSIS · CCN 672670

DaVita Sagemeadow Dialysis

HOUSTON, TX 77089

DialysisProfitDaVita
$2.8M
TOTAL REVENUE
19.3%
OPERATING MARGIN
3 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$2.8M
Total costs
$2.3M
Operating income (rev − costs)
$540K
Operating margin
19.3%
Total charges
$2.6M
Total treatments
7,378
Dialysis stations
20

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.9527—
Fistula Rate
DFC_FISTULA_RATE
69.559—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.3526—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
168.464—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1159—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
19.1254—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
17.246—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
32.449—
Standardized ED Visits Ratio
DFC_SEDR
0.720—